JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120383

UDP sodium salt (Uridine 5'-diphosphate), P2Y6 agonist. P2Y14 ligand.

UDP sodium salt (Uridine 5'-diphosphate), P2Y6 agonist. P2Y14 ligand.

Be the first to review this product! Submit a review

|

(1 Publication)

MW 470.11 Da, Purity >98%. Endogenous P2Y receptor agonist which preferentially activates P2Y6. Antagonist and agonist activities reported at human P2Y14 receptors. Potent full agonist at rat P2Y12 (EC50 = 350 nM).

別名を表示する

DKFZp686M18273, G-protein coupled receptor 17, GPR17_HUMAN, P2Y-like receptor, Probable P2Y purinoceptor GPR 17, R12, UDP/CysLT receptor, Uracil nucleotide/cysteinyl leukotriene receptor

Key facts

CAS番号

19817-91-5

精製度

>98%

製品の状態

Solid

form

分子量

470.11 Da

分子式

C<sub>9</sub>H<sub>1</sub><sub>1</sub>N<sub>2</sub>Na<sub>3</sub>O<sub>1</sub><sub>2</sub>P<sub>2</sub>

PubChem

88264

由来

Synthetic

溶解性

Soluble in water to 100 mM

化学名

Uridine 5'-(trisodium pyrophosphate)

生物学的記述

Endogenous P2Y receptor agonist which preferentially activates P2Y6. Antagonist and agonist activities reported at human P2Y14 receptors. Potent full agonist at rat P2Y12 (EC50 = 350 nM).

Canonical smiles

C1=CN(C(=O)NC1=O)C2C(C(C(O2)COP(=O)([O-])OP(=O)([O-])[O-])O)O.[Na+].[Na+].[Na+]

Isomeric smiles

C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)([O-])OP(=O)([O-])[O-])O)O.[Na+].[Na+].[Na+]

InChi

InChI=1S/C9H14N2O12P2.3Na/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18;;;/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18);;;/q;3*+1/p-3/t4-,6-,7-,8-;;;/m1.../s1

InChiKey

GFASEGWJDXDCKZ-LLWADOMFSA-K

IUPAC名

trisodium;[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] phosphate

出荷温度及び保存条件

出荷温度
Ambient - Can Ship with Ice
短期保存温度
-20°C
長期保存温度
-20°C
保管に関する情報
Store under desiccating conditions|The product can be stored for up to 12 months

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

GPR17 also known as G protein-coupled receptor 17 is a member of the G protein-coupled receptor (GPCR) family. This receptor has a molecular weight of approximately 40 kDa. It is expressed in various tissues with significant levels found in the central nervous system including the brain and spinal cord. GPR17 also shows expression in kidneys liver and heart. It is classified under the class A Rhodopsin-like family and is an orphan receptor meaning its natural ligand is not completely established but is thought to be associated with uridine nucleotides and cysteinyl leukotrienes.
Biological function summary

GPR17 is involved in several physiological processes particularly in the regulation of inflammation and myelination within the central nervous system. It plays a critical role in the differentiation of oligodendrocyte precursor cells into mature oligodendrocytes which are essential for myelin sheath formation and repair of neural damage. GPR17 is not known to function as part of a larger receptor complex but it interacts with intracellular signaling pathways to modulate these cellular processes.

Pathways

GPR17 integrates into inflammatory response pathways and neural cell development pathways. It is actively involved in the nucleotide signaling pathway which is important for responses to tissue damage and initiating repair processes. GPR17 shares functional connections with proteins such as P2Y receptors which also respond to nucleotides and are involved in diverse cellular responses including muscle contraction and platelet aggregation.

GPR17's expression and role connect it to multiple sclerosis and brain ischemia. In multiple sclerosis dysregulation of GPR17 can affect the formation and maintenance of the myelin sheath contributing to neural degeneration. During brain ischemia GPR17 activation influences the extent of injury and subsequent recovery through its effects on inflammation and tissue repair. It is linked to proteins like CXCR7 which similarly influence neural damage and repair processes in ischemic conditions.

製品プロトコール

文献 (1)

Recent publications for all applications. Explore the full list and refine your search

Disease models & mechanisms 16: PubMed37990867

2023

Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.

Applications

Unspecified application

Species

Unspecified reactive species

Leonard D Kuhrt,Edyta Motta,Nirmeen Elmadany,Hannah Weidling,Raphaela Fritsche-Guenther,Ibrahim E Efe,Olivia Cobb,Jit Chatterjee,Lucy G Boggs,Marina Schnauß,Sebastian Diecke,Marcus Semtner,Corina Anastasaki,David H Gutmann,Helmut Kettenmann
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com